Document Detail


EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy.
MedLine Citation:
PMID:  21724278     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: During inflammatory cardiomyopathy matrix metalloproteinases are crucially involved in cardiac remodeling. The aim of the present study was to investigate whether the "extracellular matrix metalloproteinase inducer" EMMPRIN (CD147) and its ligand Cyclophilin A (CyPA) are upregulated in inflammatory cardiomyopathy and may serve as diagnostic markers. Therefore, a series of 102 human endomyocardial biopsies were analyzed for the expression of EMMPRIN and CyPA and correlated with histological and immunohistological findings. METHODS AND RESULTS: Endomyocardial biopsies were stained for EMMPRIN and CyPA in addition to standard histology (HE, Trichrom) and immunohistological stainings (MHC-II, CD68, CD3). 39 (38.2%) biopsies met the immunohistological criteria of an inflammatory cardiomyopathy. EMMPRIN, which was predominantly expressed on cardiomyocytes, was slightly (but significantly) upregulated in non inflammatory cardiomyopathies compared to normal histopathological findings and highly upregulated in inflammatory cardiomyopathy compared to both non inflammatory cardiomyopathy and normal histopathology. In contrast, CyPA reveals no enhanced expression in non inflammatory cardiomyopathies and a highly enhanced expression in inflammatory cardiomyopathy, where it is closely associated with leucocytes infiltrates. We found a strong correlation between both EMMPRIN and CyPA with the expression of MHC-II molecules (correlation coefficient 0.475 and 0.527, p<0.05). Moreover, we found a correlation for both EMMPRIN and CyPA with CD68 (correlation coefficient 0.393 and 0.387, p<0.05) and CD3 (correlation coefficient 0.360 and 0.235, p<0.05). CONCLUSION: EMMPRIN is enhanced in both inflammatory and non inflammatory cardiomyopathies and can serve as a marker of myocardial remodeling. CyPA may represent a novel and specific marker for cardiac inflammation.
Authors:
Peter Seizer; Tobias Geisler; Boris Bigalke; Martin Schneider; Karin Klingel; Reinhard Kandolf; Konstantinos Stellos; Jürgen Schreieck; Meinrad Gawaz; Andreas E May
Related Documents :
9886438 - Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmi...
12569178 - Transforming growth factor beta1 exerts an autocrine regulatory effect on human endomet...
9548468 - Acquisition of granzyme b and fas ligand proteins by human keratinocytes contributes to...
21641698 - Non-substituted n-heteroaromatic selenosemicarbazone metal complexes induce apoptosis i...
7538738 - Coronary angiogenesis. from morphometry to molecular biology and back.
11118098 - Ex vivo generation of effective epstein-barr virus (ebv)-specific cd8+ cytotoxic t lymp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-1
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adiponectin and progression of arterial stiffness in hypertensive patients.
Next Document:  Evaluations of land cover risk factors for canine leptospirosis: 94 cases (2002-2009).